Key Takeaways HOLX pulled the HIV testing business in Africa from its 2025 forecast after USAID halted funding support. Tariffs from China and Costa Rica are set to increase HOLX's inventory costs by up to $25M per quarter. Hologic's Diagnostics momentum is driven by strong BV/CV test demand and Panther utilization growth.Marlborough, MA-based Hologic (HOLX) is navigating a shifting geopolitical landscape in each of its core businesses. In a conservative move, the company’s fiscal 2025 sales outlook now e ...

MongoDB (MDB) shares have plunged 54.1% in the trailing 12 months, underperforming the Zacks Computer and Technology sector, the S&P 500 index and the Zacks Internet - Software industry’s return of 3.1%, 6.9% and 10.4%, respectively.The company is facing a challenging near-term landscape due to an uncertain macroeconomic climate and rising competitive pressures. The stock has also been swept up in the broader market sell-off, driven by concerns over reduced consumer demand and the trade war. Let’s take a cl ...